Estudo da sobrevida de empresas de Santa Maria - RS no período de agosto de 2008 a agosto de 2013

Este trabalho tem como objetivo verificar o tempo de sobrevivência pelo estimador Kaplan-Meier e a taxa de mortalidade das empresas de Santa Maria utilizando o método sugerido pelo SEBRAE (2011). A análise foi baseada no banco de dados fornecido pela JUCERGS das empresas constituídas no período de agosto de 2008 a agosto de 2013. Verificou-se que a taxa de mortalidade para as empresas constituídas neste período e que permaneceram abertas durante dois anos ficou abaixo da média nacional. O setor de Construção de Edificações foi o setor mais sólido com probabilidade de uma empresa deste setor permanecer aberta após o segundo ano de atividade de 95,6%. Para uma empresa do setor de Serviços especializados para construção a probabilidade de esta permanecer em atividade após o segundo ano foi de 82,7% caindo para 75,8% à probabilidade de ela permanecer aberta após quatro anos de trabalho, indicando um setor do comércio mais vulnerável. Conclui-se, portanto, que para os setores de atividades das empresas constituídas no município tendem a permanecer em funcionamento por mais de dois anos

Burden of disease in myasthenia gravis: taking the patient’s perspective

Background: Myasthenia gravis (MG) leads to exertion-dependent muscle weakness, but also psychological and social well-being are limited. We aim to describe the burden of disease in MG including sociodemographic, economical, psychosocial as well as clinical aspects, to compare health-related quality of life (HRQoL) of patients with MG to the general population (genP) and to explore risk factors for a lower HRQoL. Methods: This case-control study was conducted with MG patients of the German Myasthenia Association. A questionnaire-based survey included sociodemographic and clinical data as well as standardized questionnaires, e.g. the Short Form Health (SF-36). HRQoL was compared to genP in a matched-pairs analysis. Participants of the German Health Interview and Examination Survey for Adults (DEGS1) served as control group. Results: In our study, 1660 MG patients participated and were compared to 2556 controls from the genP. Patients with MG showed lower levels of physical functioning (SF-36 mean 56.0, SD 30.3) compared to the genP (mean 81.8, SD 22.1, adjusted difference: 25, 95% CI 22-29) and lower mental health sub-score (SF-36 mean 67.3, SD 19.8, vs. 74.1, SD 16.7, adjusted difference: 5, 95% CI 2-8). Female gender, higher age, low income, partnership status, lower activities of daily life, symptoms of depression, anxiety and fatigue and self-perceived low social support were associated with a lower HRQoL in MG patients. Discussion: HRQoL is lower in patients with MG compared to genP. The burden of MG on patients includes economic and social aspects as well as their emotional well-being. New therapies must achieve improvements for patients in these areas

Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury

Functional recovery following incomplete spinal cord injury (SCI) depends on the rewiring of motor circuits during which supraspinal connections form new contacts onto spinal relay neurons. We have recently identified a critical role of the presynaptic organizer FGF22 for the formation of new synapses in the remodeling spinal cord. Here, we now explore whether and how targeted overexpression of FGF22 can be used to mitigate the severe functional consequences of SCI. By targeting FGF22 expression to either long propriospinal neurons, excitatory interneurons, or a broader population of interneurons, we establish that FGF22 can enhance neuronal rewiring both in a circuit-specific and comprehensive way. We can further demonstrate that the latter approach can restore functional recovery when applied either on the day of the lesion or within 24 h. Our study thus establishes viral gene transfer of FGF22 as a new synaptogenic treatment for SCI and defines a critical therapeutic window for its application

Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury

Functional recovery following incomplete spinal cord injury (SCI) depends on the rewiring of motor circuits during which supraspinal connections form new contacts onto spinal relay neurons. We have recently identified a critical role of the presynaptic organizer FGF22 for the formation of new synapses in the remodeling spinal cord. Here, we now explore whether and how targeted overexpression of FGF22 can be used to mitigate the severe functional consequences of SCI. By targeting FGF22 expression to either long propriospinal neurons, excitatory interneurons, or a broader population of interneurons, we establish that FGF22 can enhance neuronal rewiring both in a circuit‐specific and comprehensive way. We can further demonstrate that the latter approach can restore functional recovery when applied either on the day of the lesion or within 24 h. Our study thus establishes viral gene transfer of FGF22 as a new synaptogenic treatment for SCI and defines a critical therapeutic window for its application

Deposition of light-absorbing particles in glacier snow of the Sunderdhunga Valley, the southern forefront of the central Himalayas

Anthropogenic activities on the Indo-Gangetic Plain emit vast amounts of light-absorbing particles (LAPs) into the atmosphere, modifying the atmospheric radiation state. With transport to the nearby Himalayas and deposition to its surfaces the particles contribute to glacier melt and snowmelt via darkening of the highly reflective snow. The central Himalayas have been identified as a region where LAPs are especially pronounced in glacier snow but still remain a region where measurements of LAPs in the snow are scarce. Here we study the deposition of LAPs in five snow pits sampled in 2016 (and one from 2015) within 1 km from each other from two glaciers in the Sunderdhunga Valley, in the state of Uttarakhand, India, in the central Himalayas. The snow pits display a distinct enriched LAP layer interleaved by younger snow above and older snow below. The LAPs exhibit a distinct vertical distribution in these different snow layers. For the analyzed elemental carbon (EC), the younger snow layers in the different pits show similarities, which can be characterized by a deposition constant of about 50 mu g m(-2) mm(-1) snow water equivalent (SWE), while the old-snow layers also indicate similar values, described by a deposition constant of roughly 150 mu g m(-2) mm(-1) SWE. The enriched LAP layer, contrarily, displays no similar trends between the pits. Instead, it is characterized by very high amounts of LAPs and differ in orders of magnitude for concentration between the pits. The enriched LAP layer is likely a result of strong melting that took place during the summers of 2015 and 2016, as well as possible lateral transport of LAPs. The mineral dust fractional absorption is slightly below 50% for the young- and old-snow layers, whereas it is the dominating light-absorbing constituent in the enriched LAP layer, thus, highlighting the importance of dust in the region. Our results indicate the problems with complex topography in the Himalayas but, nonetheless, can be useful in large-scale assessments of LAPs in Himalayan snow.Peer reviewe

Snow albedo and its sensitivity to changes in deposited light-absorbing particles estimated from ambient temperature and snow depth observations at a high-altitude site in the Himalaya

Snow darkening by deposited light-absorbing particles (LAP) accelerates snowmelt and shifts the snow meltout date (MOD). Here, we present a simple approach to estimate the snow albedo variability due to LAP deposition and test this method with data for 2 seasons (February-May 2016 and December 2016-June 2017) at a high-altitude valley site in the Central Himalayas, India. We derive a parameterization for the snow albedo that only depends on the daily observations of average ambient temperature and change in snow depth, as well as an assumed average concentration of LAP in snow precipitation. Linear regression between observed and parameterized albedo for the base case assuming an equivalent elemental carbon concentration [ECeq] of 100 ng g(-1) in snow precipitation yields a slope of 0.75 and a Pearson correlation coefficient r(2) of 0.76. However, comparing the integrated amount of shortwave radiation absorbed during the winter season using observed albedo versus base case albedo resulted in rather small differences of 11% and 4% at the end of Seasons 1 and 2, respectively. The enhanced energy absorbed due to LAP at the end of the 2 seasons for the base case scenario (assuming an [ECeq] of 100 ng g(-1) in snow precipitation) was 40% and 36% compared to pristine snow. A numerical evaluation with different assumed [ECeq] in snow precipitation suggests that the relative sensitivity of snow albedo to changes in [ECeq] remains rather constant for the 2 seasons. Doubling [ECeq] augments the absorption by less than 20%, highlighting that the impact on a MOD is small even for a doubling of average LAP in snow precipitation.Peer reviewe

Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series

The purpose of this study was to describe the surgical outcomes and safety of intracameral bevacizumab during trabeculectomy in eyes with neovascular glaucoma. Pilot study included four eyes (four patients) with refractory neovascular glaucoma submitted to fornix-based trabeculectomy with adjunctive use of bevacizumab in the anterior chamber during the procedure. Patients were previously treated with panretinal photocoagulation as standard therapy. Variables evaluated were intraocular pressure, bleb appearance, iris neovascularization, intraoperative/postoperative complications, and visual outcomes. No intraoperative complication was observed. The mean follow-up period was 12.75 (range, 12–15 months). All eyes showed significant intraocular pressure control postoperatively. Iris neovascularization reduced significantly within 1 month after surgery. Mild anterior chamber inflammation was observed during follow-up in all eyes. No significant postoperative complication was observed, and no patient presented visual acuity deterioration. Intracameral bevacizumab may be used as an adjunctive therapy during trabeculectomy in eyes with neovascular glaucoma